Respicardia

Respicardia, Inc. is dedicated to developing implantable neurostimulation therapies that improve respiratory rhythm and thereby enhance cardiovascular health, aiming to improve the lives of patients with heart failure. The company is committed to advancing the commercialization of its implantable neurostimulation treatment device, the remedē® System, in the United States for the treatment of sleep apnea syndrome in heart failure patients.